Clinical Trial Update: A Phase Ib Study of RC148 as Monotherapy or Combination for Locally Advanced or Metastatic NSCLC [Phase 1]

View source ↗

Summary

This document describes a Phase Ib trial of RC148 as a monotherapy or in combination for locally advanced or metastatic non-small cell lung cancer, which is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• RC148 (RC148)

Snippet

Sponsor: RemeGen Co., Ltd. | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING